Literature DB >> 9659245

Comparison of throat swabs with sputum specimens for the detection of Chlamydia pneumoniae antigen by direct immunofluorescence.

P Garnett1, O Brogan, C Lafong, C Fox.   

Abstract

AIM: To compare throat swabs with sputum specimens for Chlamydia pneumoniae antigen detection.
METHODS: During a one year period, sputum and throat swabs from 50 patients over 15 years of age with acute or persisting lower respiratory tract infection were examined for C pneumoniae antigen by direct immunofluorescence.
RESULTS: C pneumoniae antigen was detected in 18/50 patients (36.0%) from sputum, throat swab, or both. Paired sputum and throat swabs were received from 35/50 patients (70.0%). C pneumoniae antigen was detected in either or both specimens from 14/35 patients (40.0%). Of the 14 positive patients, both specimens were positive in nine (64.3%), throat swab only in four (28.6%), and sputum only in one (7.1%). Of the remaining 15 patients from whom only a single specimen was sent, a further three of eight throat swabs and one of seven sputum specimens were positive. There was no statistically significant difference between the results obtained from the two types of specimen.
CONCLUSIONS: Throat swabs may be as good as sputum for the detection of C pneumoniae antigen.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9659245      PMCID: PMC500676          DOI: 10.1136/jcp.51.4.309

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  7 in total

1.  Association of Chlamydia pneumoniae IgA antibodies with recently symptomatic asthma.

Authors:  D L Hahn; T Anttila; P Saikku
Journal:  Epidemiol Infect       Date:  1996-12       Impact factor: 2.451

2.  Detection of Chlamydia pneumoniae and Chlamydia psittaci in sputum samples by PCR.

Authors:  C Y Tong; M Sillis
Journal:  J Clin Pathol       Date:  1993-04       Impact factor: 3.411

3.  Evaluation of a microdot immunofluorescent antigen detection test for Chlamydia trachomatis.

Authors:  C Thompson; R Jones; B Smith; O Brogan; I W Smith; D Carrington
Journal:  Genitourin Med       Date:  1994-08

Review 4.  Chlamydia pneumoniae (TWAR).

Authors:  C C Kuo; L A Jackson; L A Campbell; J T Grayston
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

5.  The differentiation of Chlamydia species by antigen detection in sputum specimens from patients with community-acquired acute respiratory infections.

Authors:  M Sillis; P White; E O Caul; I D Paul; J D Treharne
Journal:  J Infect       Date:  1992-07       Impact factor: 6.072

6.  Diagnosis of Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease by micro-immunofluorescence and ELISA.

Authors:  R P Verkooyen; N A Van Lent; S A Mousavi Joulandan; R J Snijder; J M van den Bosch; H P Van Helden; H A Verbrugh
Journal:  J Med Microbiol       Date:  1997-11       Impact factor: 2.472

7.  Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease.

Authors:  M A Mendall; D Carrington; D Strachan; P Patel; N Molineaux; J Levi; T Toosey; A J Camm; T C Northfield
Journal:  J Infect       Date:  1995-03       Impact factor: 6.072

  7 in total
  2 in total

Review 1.  Molecular diagnosis of Chlamydia pneumoniae infection.

Authors:  J Boman; C A Gaydos; T C Quinn
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.